other

Sherin 1998 HITS from four caller-assigned integers 1-5 (hurt, insult, threaten, scream; never=1 to frequently=5). magent does not interview the patient or interpret the items. Sum 4-20. Screen-positive when score ≥10. Deterministic published score with citation; not a diagnosis of intimate partner violence and not a medical device.

Mearin 2016 Rome IV C6 OIC. rome_iv_oic is true iff new or worsening constipation when initiating, changing, or increasing opioid therapy, at least 2 of 6 symptoms (straining, lumpy/hard stools, incomplete evacuation, anorectal obstruction, manual maneuvers, fewer than 3 SBM/week), and loose stools rare without laxatives. symptom_count is 0-6. Caller assigns eight flags. magent does not examine the patient or prescribe opioids. Not a diagnosis, not functional constipation C2, not IBS, not child.

Webb 2016 DRIP (drug resistance in pneumonia): ten caller-assigned flags, four major at 2 points and six minor at 1, max 14. high_risk if score >= 4. Deterministic published score with citation; not a medical device, not an antibiotic order, and not HCAP. magent does not classify the facility or compute Karnofsky.

Yeh 2016 DAPT prediction rule after PCI: exclusive age (<65: 0; 65 to younger than 75: -1; 75 or older: -2) plus MI at presentation, prior MI or PCI, diabetes, stent diameter <3 mm, smoking (current or within past year), and paclitaxel-eluting stent (1 each); CHF or LVEF <30% and vein-graft intervention (2 each). Max 10. Score >=2 high, <2 low. Not a duration order. Not a diagnosis.

Dagan 1985 Rochester criteria. Low-risk only if the infant is younger than 3 months (age_days 0-89) and every caller-assigned finding holds: previously healthy term infant, well appearing, no ear/soft-tissue/skeletal infection, WBC 5000-15000/mm3 inclusive, absolute band count <1500/mm3, UA <=10 WBC/hpf, and stool <=5 WBC/hpf if diarrhea. Returns low_risk. magent does not examine the infant. Not Boston, Philadelphia, or PECARN febrile infant 2021. Not a medical device and not a discharge order.

Pediatric NEXUS II (Gupta 2018). Low-risk iff all seven flags are false: skull fracture, scalp hematoma, neurologic deficit, altered alertness, abnormal behavior, persistent vomiting, and coagulopathy. Age 0-17 is required but is not a criterion; adult NEXUS Head CT age >= 65 is dropped. Not a diagnosis, not a CT order, not Mower 2017 adult NEXUS Head CT, not PECARN, CATCH, or CHALICE, and not Hoffman 2000 NEXUS C-spine. magent does not examine the patient.

Dutch Lipid Clinic Network (Nordestgaard 2013 Table 1) familial hypercholesterolaemia score. One LDL (mmol/L or mg/dL / 38.67) plus family, clinical, physical, and DNA groups; per group only the highest. Max 26. Definite >8, probable 6-8, possible 3-5, unlikely 0-2. Score 8 (mutation alone) is probable. Adult Table 1 only; not Simon Broome, not MEDPED, not homozygous FH. magent does not assay lipids, examine tendons or arcus, or sequence genes. Not a medical device and not a diagnosis of FH.

Schmitz 2016 CNS-IPI: Shipp IPI factors (age >60, ECOG ≥2, LDH > ULN, Ann Arbor III or IV, extranodal sites >1) plus kidney and/or adrenal involvement; 1 point each, max 6. Low 0–1, intermediate 2–3, high 4–6. CNS relapse risk after R-CHOP in DLBCL. Deterministic published score; not a CNS prophylaxis or LP order; not NCCN-IPI; not R-IPI; not a DLBCL diagnosis. magent does not stage lymphoma or image kidneys.

Yokoe 2018 TG18 (=TG13) acute cholecystitis. Definite if local signs (Murphy or RUQ mass/pain/tenderness), systemic signs (fever, elevated CRP or WBC), and imaging; suspected if local and systemic without imaging; else none. Suspected/definite: Grade III if any organ dysfunction, else Grade II if any Grade II flag, else Grade I. Severity none when diagnosis is none. Not cholangitis or Alvarado/RIPASA. magent does not examine, assay, or read imaging. Not a medical device.

Maxwell 2008 Nottingham hip fracture score: age <=65 0, 66-85 3, >=86 4; male 1; hemoglobin <=10 g/dL 1 (g/L / 10); caller-assigned AMTS <=6, lives in institution, >=2 comorbidities, and malignancy 1 each. Max 10. Integer score only; no predicted 30-day mortality percent. magent does not administer AMTS or clear a patient for surgery. Not the 2012 or 2015 recalibrations.

Smith 2012 unweighted modified Sgarbossa for STEMI equivalent in LBBB. Positive if ANY of three caller-assigned flags is true: concordant ST elevation ≥1 mm in a lead with positive QRS, concordant ST depression ≥1 mm in V1–V3, or ≥1 mm discordant STE with ST/S ratio ≤ −0.25 (STE ≥25% of the preceding S-wave). Not the original Sgarbossa 1996 5/3/2 points score. Not a 5 mm discordant rule. magent does not measure the ECG. Not a diagnosis.

Binet 1981 CLL staging. Stage C if anemia (Hb <10 g/dL) or thrombocytopenia (platelets <100×10^9/L), regardless of lymphoid areas. Else stage B when involved_areas is 3-5, else stage A when 0-2. The five areas are cervical, axillary, and inguinal (unilateral or bilateral counts as one area each), plus spleen, plus liver; the caller assigns the count. Not a medical device, not a CLL diagnosis, and not Rai staging (Rai anemia is Hb <11).

Murray 1988 lung injury score (LIS): mean of four 0–4 components (caller-assigned CXR quadrants; PaO2/FiO2 ≥300→0, 225–299→1, 175–224→2, 100–174→3, <100→4; PEEP cm H2O ≤5→0, 6–8→1, 9–11→2, 12–14→3, ≥15→4; compliance mL/cm H2O ≥80→0, 60–79→1, 40–59→2, 20–39→3, ≤19→4). LIS 0 none, 0<LIS≤2.5 mild_moderate, >2.5 severe. Not a medical device, not a Berlin ARDS diagnosis, not a ventilator order. magent does not interpret imaging.

Tavaglione 2023 fibrotic NASH index (FNI) from AST, HbA1c, and HDL cholesterol. FNI = e^x/(1+e^x) with x = -10.33 + 2.54*ln(AST) + 3.86*ln(HbA1c) - 1.66*ln(HDL mg/dL). HDL may be mg/dL or mmol/L (×38.67). Rule-out ≤0.10; indeterminate between 0.10 and 0.33; rule-in ≥0.33. Not a biopsy, not FIB-4, not the NAFLD fibrosis score, not SAFE, and not BARD.

REMS from Olsson 2004 Table 1: MAP, heart rate, respiratory rate, SpO2, GCS (RAPS 0–4, not 15−GCS), and age summed to a 0–26 total for nonsurgical adult ED in-hospital mortality. Deterministic published arithmetic with citation; not MEWS, NEWS, or APACHE II; not an ICU-admission order.

Samsoon 1987 modified Mallampati: caller-assigned integer class 1-4 (I: soft palate, fauces, uvula, pillars; II: soft palate, fauces, uvula; III: soft palate, base of uvula; IV: soft palate not visible). Returns score, max 4, and a stable class label. Not original Mallampati 1985 three-class and not a Cormack-Lehane grade; magent does not look in the mouth or assign an intubation order.

Lima 2016 FAST-ED (Field Assessment Stroke Triage for Emergency Destination): facial_palsy 0-1 + arm_weakness 0-2 + speech 0-2 + eye_deviation 0-2 + neglect 0-2. Max 9. lvo_suggested iff score ≥4. Bands 0_to_1 / 2_to_3 / gte_4. Time is documented for decision making (0 points, not scored). Not a stroke diagnosis or transfer order. magent does not examine the patient.

Schroeder 1987 ulcerative colitis disease-activity index (Mayo DAI): four caller-assigned integers 0-3 (stool frequency, rectal bleeding, endoscopy, physician global). magent sums only (max 12) and does not return later remission or activity-band cutoffs. magent does not count stools, examine the patient, or perform endoscopy. Not a diagnosis and not the Mayo SPN pulmonary-nodule model.

Rockwood 2005 CSHA Clinical Frailty Scale 1-7 as assigned by the caller (Box 1). Returns cfs, score, max 7, and the published label. Does not implement the later 9-point CFS (8 very severely frail, 9 terminally ill) or CFS 2.0 label changes. Not a diagnosis; magent does not examine the patient.

Caprini 2005 thrombosis risk assessment (Table 3): exclusive age (41-60=1, 61-74=2, >=75=3) and exclusive surgery (minor=1; arthroscopic/major/laparoscopic=2; arthroplasty=5) plus caller-assigned 1-, 2-, 3-, and 5-point flags. Max 78. Bands: 0-1 low, 2 moderate, 3-4 high, >=5 highest. Not a diagnosis. Not Caprini 2009/2013. Not a prophylaxis order.

Davis 2017 HEAVEN criteria from six caller-assigned flags: hypoxemia (SpO2 ≤93% at initial laryngoscopy as assigned), extremes of size (pediatric ≤8 years or clinical obesity as assigned), anatomic challenges, vomit/blood/fluid, exsanguination, and limited neck mobility. high_risk iff any is true; criteria_met is the count of true flags (0-6); low_risk iff none. Not an intubation order. magent does not measure SpO2 or examine the airway. Not Mallampati, not EGRI.

Condoluci 2020 IPS-E for asymptomatic early-stage chronic lymphocytic leukemia: unmutated IGHV 1, ALC >15 ×10^9/L 1, palpable lymph nodes 1; max 3. Low 0, intermediate 1, high 2–3. Time-to-first-treatment score, not a treatment start order; not CLL-IPI, Rai, or Binet. magent does not assay IGHV, count lymphocytes, or palpate nodes.

WHO 2016 polycythemia vera criteria (Arber 2016). Met when all three majors hold, or when major 1 and major 2 hold with subnormal EPO. Major 1 is male Hb >16.5 g/dL or Hct >49%, female Hb >16.0 or Hct >48%, or increased red-cell mass. Major 2 is caller-assigned marrow panmyelosis. Major 3 is JAK2 V617F or exon 12. Not a medical device, not a WHO diagnosis, and not WHO 2022. magent does not assay EPO or sequence JAK2.

Chopra 2017 Michigan Risk Score for PICC-associated thrombosis: another CVC at PICC placement 1, WBC >12 x10^9/L 1 (12.0 does not score), active cancer 2, PICC lumens single 0 / double 2 / triple 3 (triple includes quad), VTE history never 0 / remote 2 / within 30 days 3 (one field; do not add remote and recent). Max 10. Classes I=0 (observed 0.9%), II=1-2 (1.6%), III=3-4 (2.7%), IV=>4 (4.7% Table 4). Not a PICC order. magent does not count lumens.